Cargando…
Health Care Costs and Thromboembolic Events in Hydroxyurea-Treated Patients with Polycythemia Vera
BACKGROUND: Patients with polycythemia vera (PV) are at increased risk of thromboembolic events (TEs), which are key contributors to reduced overall survival compared with the age- and sex-matched general population. In addition to aspirin and phlebotomy to maintain hematocrit level < 45%, many p...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Academy of Managed Care Pharmacy
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397887/ https://www.ncbi.nlm.nih.gov/pubmed/29290171 http://dx.doi.org/10.18553/jmcp.2018.24.1.47 |